HROW Harrow Health, Inc.

HealthcareDrug Manufacturers - Specialty & Generic
$39.05
3.03%
39
QScore Signal
Hold
Confidence: MEDIUM
Long-Term
35
Short-Term
43

Value

19
P/E-279.33
8
P/B27.37
29
P/S5.35
45
EV/EBITDA42.92
0

Growth

71
Revenue Growth36.4%
100
EPS Growth71.4%
48
FCF Growth170.6%
63

Momentum

57
12-Month Return61.9%
93
3-Month Return-15.2%
36
1-Month Return6.3%
65
RSI (14)37.36
50
50/200 MABearish
30

Profitability

37
ROE-10.0%
49
ROA-1.3%
15
Gross Margin75.1%
62
Operating Margin11.2%
36
Net Margin-1.9%
23
FCF Yield2.9%
32

Risk

16
Beta0.34
35
60-Day Volatility80.3%
0

Generated 5/7/2026, 11:38:43 PM · How is this calculated?

QScore Analysis